In Silico Tools in PROTACs design
Mengman Wei

TL;DR
This paper reviews recent computational in silico tools that aim to accelerate and improve the design process of PROTACs, a promising therapeutic modality, by supplementing traditional experimental methods.
Contribution
It provides a concise summary of recent in silico tools developed for PROTACs design, highlighting their potential to streamline drug development.
Findings
In silico tools can potentially reduce time and cost in PROTACs development.
Recent computational methods include molecular modeling and virtual screening techniques.
These tools complement experimental approaches to improve druggability assessment.
Abstract
PROTACs, as a highly promising new. therapeutic paradigm, have attracted widespread attention from the academic and pharmaceutical communities in recent years. To date, the design and validation of PROTACs molecule's druggability primarily rely on experimental approaches, making the development process of this kind of drug molecule time-consuming. Computer-aided tools for PROTACs design may offer a potential solution to expedite the design process and enhance its efficiency. This mini review briefly summarizes the in silico tools for PROTACs drug molecule design reported recently.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProtein Degradation and Inhibitors · Computational Drug Discovery Methods · 14-3-3 protein interactions
